• THAT   AND
  • THAT   AND


Homo sapiens cylindromatosis (turban tumor syndrome) (CYLD), transcript variant 3, mRNA.


RefSeq Accession Definition Sequence Price Select
NM_001042412 Homo sapiens cylindromatosis (turban tumor syndrome) (CYLD), transcript variant 3, mRNA. Full Lenth Quote
ORF Sequence $829.98


RefSeq Version NM_001042412.1, 109637775
Length 8608 bp
Structure linear
Update Date 11-MAR-2011
Organism Homo sapiens (human)
Definition Homo sapiens cylindromatosis (turban tumor syndrome) (CYLD), transcript variant 3, mRNA.
Product ubiquitin carboxyl-terminal hydrolase CYLD isoform 2
Comment

Summary: This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq].


Transcript Variant: This variant (3) has an alternate 5' terminal exon, and lacks one exon in the 5' UTR and another in-frame exon in the coding region, compared to variant 1, resulting in a shorter protein (isoform 2), compared to isoform 1. Variants 2 and 3 encode the same isoform.

RefSeq NP_001035877.1
CDS 303..3164
Exon (1)1..99
Exon (2)1..99
Exon (3)100..179
Exon (4)180..806
Exon (5)807..1109
Exon (6)1110..1215
Exon (7)1216..1314
Exon (8)1315..1431
Exon (9)1432..1811
Exon (10)1812..1977
Exon (11)1978..2119
Exon (12)2120..2242
Exon (13)2243..2334
Exon (14)2335..2401
Exon (15)2402..2534
Exon (16)2535..2643
Exon (17)2644..2762
Exon (18)2763..2979
Exon (19)2980..8591
Translation MSSGLWSQEKVTSPYWEERIFYLLLQECSVTDKQTQKLLKVPKGSIGQYIQDRSVGHSRI PSAKGKKNQIGLKILEQPHAVLFVDEKDVVEINEKFTELLLAITNCEERFSLFKNRNRLS KGLQIDVGCPVKVQLRSGEEKFPGVVRFRGPLLAERTVSGIFFGVELLEEGRGQGFTDGV YQGKQLFQCDEDCGVFVALDKLELIEDDDTALESDYAGPGDTMQVELPPLEINSRVSLKV GETIESGTVIFCDVLPGKESLGYFVGVDMDNPIGNWDGRFDGVQLCSFACVESTILLHIN DIIPESVTQERRPPKLAFMSRGVGDKGSSSHNKPKATGSTSDPGNRNRSELFYTLNGSSV DSQPQSKSKNTWYIDEVAEDPAKSLTEISTDFDRSSPPLQPPPVNSLTTENRFHSLPFSL TKMPNTNGSIGHSPLSLSAQSVMEELNTAPVQESPPLAMPPGNSHGLEVGSLAEVKENPP FYGVIRWIGQPPGLNEVLAGLELEDECAGCTDGTFRGTRYFTCALKKALFVKLKSCRPDS RFASLQPVSNQIERCNSLAFGGYLSEVVEENTPPKMEKEGLEIMIGKKKGIQGHYNSCYL DSTLFCLFAFSSVLDTVLLRPKEKNDVEYYSETQELLRTEIVNPLRIYGYVCATKIMKLR KILEKVEAASGFTSEEKDPEEFLNILFHHILRVEPLLKIRSAGQKVQDCYFYQIFMEKNE KVGVPTIQQLLEWSFINSNLKFAEAPSCLIIQMPRFGKDFKLFKKIFPSLELNITDLLED TPRQCRICGGLAMYECRECYDDPDISAGKIKQFCKTCNTQVHLHPKRLNHKYNPVSLPKD LPDWDWRHGCIPCQNMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNI PQVTPCPEVGEYLKMSLEDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK
Order your protein of interest with our Guaranteed or It's Free Service now! For details, please click here.
Position Chain Variation Link
203..204+, adbSNP:67190903
389+c, tdbSNP:34564491
820+a, gdbSNP:12599808
1431+, adbSNP:67074993
1766+c, tdbSNP:75757530
2533+a, gdbSNP:121908389
2565+c, tdbSNP:121908388
2705+c, tdbSNP:2066852
2891+a, cdbSNP:117347778
2899+a, cdbSNP:118122197
3099+c, tdbSNP:121908390
3211+a, gdbSNP:116979331
3252+g, tdbSNP:74822565
3400+a, gdbSNP:117713908
complement(4001)-t, cdbSNP:3743781
4005+a, gdbSNP:117537927
4237+a, cdbSNP:116971974
4286+a, gdbSNP:114552144
5264+a, cdbSNP:76274836
5269..5271+, ggadbSNP:75414200
5271+, adbSNP:111804189
5272+a, gdbSNP:79868875
5284..5286+, aaadbSNP:74757288
5286+a, gdbSNP:117053677
5288+a, gdbSNP:118042635
5400+c, tdbSNP:57638820
5499+c, tdbSNP:9646285
5533+a, gdbSNP:16948829
5840+a, cdbSNP:76888453
6403+a, gdbSNP:34088926
6633+c, tdbSNP:111951225
6903+c, gdbSNP:16948836
7725+a, gdbSNP:17314948
7731+c, tdbSNP:113748745
7779..7780+, gdbSNP:34262697
Gene SymbolCYLD
Gene SynonymCDMT; CYLD1; CYLDI; EAC; FLJ20180; FLJ31664; FLJ78684; HSPC057; KIAA0849; MFT; MFT1; SBS; TEM; USPL2
Chromosome16
Locus Map16q12.1
All Transcripts NM_001042412 , NM_001042355 , NM_015247
Title An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells .
Author Alameda,J.P., Moreno-Maldonado,R., Navarro,M., Bravo,A., Ramirez,A., Page,A., Jorcano,J.L., Fernandez-Acenero,M.J. and Casanova,M.L.
Journal Oncogene 29 (50), 6522-6532 (2010)
Title Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study .
Author Bailey,S.D., Xie,C., Do,R., Montpetit,A., Diaz,R., Mohan,V., Keavney,B., Yusuf,S., Gerstein,H.C., Engert,J.C. and Anand,S.
Journal Diabetes Care 33 (10), 2250-2253 (2010)
Title The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia .
Author Espinosa,L., Cathelin,S., D'Altri,T., Trimarchi,T., Statnikov,A., Guiu,J., Rodilla,V., Ingles-Esteve,J., Nomdedeu,J., Bellosillo,B., Besses,C., Abdel-Wahab,O., Kucine,N., Sun,S.C., Song,G., Mullighan,C.C., Levine,R.L., Rajewsky,K., Aifantis,I. and Bigas,A.
Journal Cancer Cell 18 (3), 268-281 (2010)
Title STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer .
Author Iliopoulos,D., Jaeger,S.A., Hirsch,H.A., Bulyk,M.L. and Struhl,K.
Journal Mol. Cell 39 (4), 493-506 (2010)
Title Frameshift mutations of ATBF1, WNT9A, CYLD and PARK2 in gastric and colorectal carcinomas with high microsatellite instability .
Author An,C.H., Kim,S.S., Kang,M.R., Kim,Y.R., Kim,H.S., Yoo,N.J. and Lee,S.H.
Journal Pathology 42 (6), 583-585 (2010)
Title Identification of the familial cylindromatosis tumour-suppressor gene .
Author Bignell,G.R., Warren,W., Seal,S., Takahashi,M., Rapley,E., Barfoot,R., Green,H., Brown,C., Biggs,P.J., Lakhani,S.R., Jones,C., Hansen,J., Blair,E., Hofmann,B., Siebert,R., Turner,G., Evans,D.G., Schrander-Stumpel,C., Beemer,F.A., van Den Ouweland,A., Halley,D., Delpech,B., Cleveland,M.G., Leigh,I., Leisti,J. and Rasmussen,S.
Journal Nat. Genet. 25 (2), 160-165 (2000)
Title Brooke-Spiegler syndrome locus assigned to 16q12-q13 .
Author Fenske,C., Banerjee,P., Holden,C. and Carter,N.
Journal J. Invest. Dermatol. 114 (5), 1057-1058 (2000)
Title A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16 .
Author Thomson,S.A., Rasmussen,S.A., Zhang,J. and Wallace,M.R.
Journal Hum. Genet. 105 (1-2), 171-173 (1999)
Title The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas .
Author Biggs,P.J., Chapman,P., Lakhani,S.R., Burn,J. and Stratton,M.R.
Journal Oncogene 12 (6), 1375-1377 (1996)
Title Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene .
Author Biggs,P.J., Wooster,R., Ford,D., Chapman,P., Mangion,J., Quirk,Y., Easton,D.F., Burn,J. and Stratton,M.R.
Journal Nat. Genet. 11 (4), 441-443 (1995)

Our customer service representatives are available 24 hours a day, Monday through Friday; please contact us anytime for assistance.

Secured Online Quotation
Email: gene@genscript.com
Phone: 1-877-436-7274 (Toll-Free) 1-732-885-9188
Fax: 1-732-210-0262 1-732-885-5878